Memantina, un antagonista de receptores N-metil-D-aspartato como posible futura terapia pata las discinesias asociadas a la toma de levodopa en Parkinson. Los pacientes suelen reportar estos efectos secundarios como uno de los de mayor impacto sobre la cal
14,783 followers
10,524 followers
Intrastriatal infusion of non-competitive NMDA receptor antagonist Memantine reported to reduce Levodopa-induced dyskinesia & motor deficits in a mouse model of hemi-#Parkinsons https://t.co/P8geiysbZn https://t.co/JF2Tq5DRZu
10,527 followers
New Research: Intrastriatal Memantine Infusion Dampens Levodopa-Induced Dyskinesia and Motor Deficits in a Mouse Model of Hemiparkinsonism: Although the administration of dopamine precursor levodopa remains as the mainstay for the treatment of… https://t.c